Inventiva (IVA) Non-Current Assets (2018 - 2025)
Inventiva's (IVA) quarterly Non-Current Assets came in at $5.9 million in Q4 2025, down 99.93% year-on-year from $8.0 billion in Q4 2024, and down 99.92% quarter-over-quarter from $7.0 billion in Q2 2025.
Inventiva (IVA) Non-Current Assets (2018 - 2025) Analysis & Trends
Inventiva's Non-Current Assets history runs 8 years deep, the most recent figure standing at $5.9 million for Q4 2025.
- On a quarterly basis, Non-Current Assets fell 99.93% year-over-year to $5.9 million in Q4 2025; TTM through Dec 2025 was $57.2 million, a 99.28% decrease from a year earlier, with the FY2025 full-year figure at $5.9 million, down 99.93% from the prior year.
- Non-Current Assets fell to $5.9 million in Q4 2025 per IVA's latest filing, from $7.0 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $9.0 billion in Q2 2022 and bottomed at $5.9 million in Q4 2025.
- The 5-year median for Non-Current Assets is $20.8 million (2023), against an average of $3.1 billion.
- Across the five-year window, Non-Current Assets surged 103703.96% in 2021 and tumbled 99.93% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $7.3 billion in 2021, then plunged by 99.87% to $9.8 million in 2022, then soared by 134.27% to $23.0 million in 2023, then soared by 34548.63% to $8.0 billion in 2024, then tumbled by 99.93% to $5.9 million in 2025.
- Per Business Quant, the three latest IVA Non-Current Assets figures stand at $5.9 million (Q4 2025), $7.0 billion (Q2 2025), and $8.0 billion (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | 5.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.87 Mn |
| Jun 30, 2025 | 6.95 Bn |
| Dec 31, 2024 | 7.97 Bn |
| Jun 30, 2024 | 18.54 Mn |
| Dec 31, 2023 | 22.99 Mn |
| Dec 31, 2022 | 9.82 Mn |
| Jun 30, 2022 | 9.03 Bn |
| Dec 31, 2021 | 7.33 Bn |
| Jun 30, 2021 | 8.89 Mn |
| Mar 31, 2021 | 8.21 Mn |
| Dec 31, 2020 | 7.06 Mn |
| Jun 30, 2020 | 9.42 Mn |
| Dec 31, 2019 | 8.95 Mn |
| Dec 31, 2018 | 9.33 Mn |